Ranbaxy Life Science Research

Rediff.com » News » Ranbaxy Life Science Research

News for Ranbaxy Life Science Research

Business

'Whatever I have is because of India'

'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from India.''India is showing that in a very competitive environment -- like the US and......

Sensex ends in the red amid volatile trade; IT, auto, realty fall

The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,542.95. Benchmark indices ended marginally lower, amid volatile trading session,......

Sensex falls 251 points; oil and gas shares tumble

Markets ended lower on Friday, amid weakness in European shares, dragged by oil shares because of declining global crude oil prices. Adding to this, investors were cautious ahead of CPI and IIP......

Pharma M&As to drive Infosys' life sciences biz

Infosys, India’s second largest software services company, expects the recent spate of mergers and acquisitions in the global pharmaceutical sector to boost its life sciences business over......

India acts to repair reputation as drugs exporter

India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by US Food and Drug Administration on several suppliers, two top......

Rediff News

Ranbaxy Life Science Research

News for Ranbaxy Life Science Research

'Whatever I have is because of India'

Sensex ends in the red amid volatile trade; IT, auto, realty fall

Sensex falls 251 points; oil and gas shares tumble

Pharma M&As to drive Infosys' life sciences biz

India acts to repair reputation as drugs exporter

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS